MedTrace Logo

A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China

NCT01307410 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2013-02-15

No results posted yet for this study

Summary

In 2010, the sponsor conducted an observational study, entitled as "Nationwide Assessment of Cardiovascular Risk Factors: Blood Pressure, Blood Lipid, and Blood Glucose, in Chinese Patients with Type 2 Diabetes - 3B Study " which was to evaluate the level of cardiovascular diseases (CVD) risk factor control and its regional difference in China. As a continuation, this extension of the 3B Study is designed to assess the incidence of cardiovascular events, cardio-renal events, and other microvascular complications, in 1, 2 and 3 years in patients with type 2 diabetes and with high risk of (CVD) with or without existing or history of coronary artery diseases.

Conditions

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • VitalStrategic Research Institute

    collaborator OTHER

  • China Gerontological Society

    collaborator OTHER

  • Chinese Medical Doctor Association

    collaborator OTHER

  • China Cardiometabolic Registries

    lead NETWORK

Principal Investigators

  • Linong Ji, MD · People's Hospital, Beijing University

  • Dayi Hu, MD · People's Hospital, Beijing University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-05-31
Completion
2014-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01307410 on ClinicalTrials.gov